These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

1076 related items for PubMed ID: 32144874

  • 1. The influence of HIV-related stigma on PrEP disclosure and adherence among adolescent girls and young women in HPTN 082: a qualitative study.
    Velloza J, Khoza N, Scorgie F, Chitukuta M, Mutero P, Mutiti K, Mangxilana N, Nobula L, Bulterys MA, Atujuna M, Hosek S, Heffron R, Bekker LG, Mgodi N, Chirenje M, Celum C, Delany-Moretlwe S, HPTN 082 study group.
    J Int AIDS Soc; 2020 Mar; 23(3):e25463. PubMed ID: 32144874
    [Abstract] [Full Text] [Related]

  • 2. Experiences of oral pre-exposure prophylaxis (PrEP) use disclosure among South African adolescent girls and young women and its perceived impact on adherence.
    Giovenco D, Gill K, Fynn L, Duyver M, O'Rourke S, van der Straten A, Morton JF, Celum CL, Bekker LG.
    PLoS One; 2021 Mar; 16(3):e0248307. PubMed ID: 33667264
    [Abstract] [Full Text] [Related]

  • 3. PrEP uptake, persistence, adherence, and effect of retrospective drug level feedback on PrEP adherence among young women in southern Africa: Results from HPTN 082, a randomized controlled trial.
    Celum C, Hosek S, Tsholwana M, Kassim S, Mukaka S, Dye BJ, Pathak S, Mgodi N, Bekker LG, Donnell DJ, Wilson E, Yuha K, Anderson PL, Agyei Y, Noble H, Rose SM, Baeten JM, Fogel JM, Adeyeye A, Wiesner L, Rooney J, Delany-Moretlwe S.
    PLoS Med; 2021 Jun; 18(6):e1003670. PubMed ID: 34143779
    [Abstract] [Full Text] [Related]

  • 4. How a menu of adherence support strategies facilitated high adherence to HIV prevention products among adolescent girls and young women in sub-Saharan Africa: a mixed methods analysis.
    Roberts ST, Mancuso N, Williams K, Nabunya HK, Mposula H, Mugocha C, Mvinjelwa P, Garcia M, Szydlo DW, Soto-Torres L, Ngure K, Hosek S.
    J Int AIDS Soc; 2023 Nov; 26(11):e26189. PubMed ID: 37936551
    [Abstract] [Full Text] [Related]

  • 5. Assessing longitudinal patterns of depressive symptoms and the influence of symptom trajectories on HIV pre-exposure prophylaxis adherence among adolescent girls in the HPTN 082 randomized controlled trial.
    Velloza J, Hosek S, Donnell D, Anderson PL, Chirenje M, Mgodi N, Bekker LG, Delany-Moretlwe S, Celum C, HPTN 082 study group.
    J Int AIDS Soc; 2021 Jun; 24 Suppl 2(Suppl 2):e25731. PubMed ID: 34164929
    [Abstract] [Full Text] [Related]

  • 6. The Community PrEP Study: a randomized control trial leveraging community-based platforms to improve access and adherence to pre-exposure prophylaxis to prevent HIV among adolescent girls and young women in South Africa-study protocol.
    Medina-Marino A, Bezuidenhout D, Hosek S, Barnabas RV, Atujuna M, Bezuidenhout C, Ngwepe P, Peters RPH, Little F, Celum CL, Daniels J, Bekker LG.
    Trials; 2021 Jul 26; 22(1):489. PubMed ID: 34311754
    [Abstract] [Full Text] [Related]

  • 7. Experiences with HPTN 067/ADAPT Study-Provided Open-Label PrEP Among Women in Cape Town: Facilitators and Barriers Within a Mutuality Framework.
    Amico KR, Wallace M, Bekker LG, Roux S, Atujuna M, Sebastian E, Dye BJ, Elharrar V, Grant RM.
    AIDS Behav; 2017 May 26; 21(5):1361-1375. PubMed ID: 27317411
    [Abstract] [Full Text] [Related]

  • 8. Integrating a mental health intervention into PrEP services for South African young women: a human-centred implementation research approach to intervention development.
    Velloza J, Ndimande-Khoza N, Mills L, Concepcion T, Gumede S, Chauke H, Verhey R, Chibanda D, Hosek S, Weiner BJ, Celum C, Delany-Moretlwe S.
    J Int AIDS Soc; 2024 Jul 26; 27 Suppl 1(Suppl 1):e26274. PubMed ID: 38965973
    [Abstract] [Full Text] [Related]

  • 9. Uptake of and adherence to oral pre-exposure prophylaxis among adolescent girls and young women at high risk of HIV-infection in Kampala, Uganda: A qualitative study of experiences, facilitators and barriers.
    Kayesu I, Mayanja Y, Nakirijja C, Machira YW, Price M, Seeley J, Siu G.
    BMC Womens Health; 2022 Nov 10; 22(1):440. PubMed ID: 36357920
    [Abstract] [Full Text] [Related]

  • 10. Relationship dynamics and anticipated stigma: Key considerations for PrEP use among Tanzanian adolescent girls and young women and male partners.
    Jani N, Mathur S, Kahabuka C, Makyao N, Pilgrim N.
    PLoS One; 2021 Nov 10; 16(2):e0246717. PubMed ID: 33596216
    [Abstract] [Full Text] [Related]

  • 11. Alignment of PrEP adherence with periods of HIV risk among adolescent girls and young women in South Africa and Zimbabwe: a secondary analysis of the HPTN 082 randomised controlled trial.
    Velloza J, Donnell D, Hosek S, Anderson PL, Chirenje ZM, Mgodi N, Bekker LG, Marzinke MA, Delany-Moretlwe S, Celum C.
    Lancet HIV; 2022 Oct 10; 9(10):e680-e689. PubMed ID: 36087612
    [Abstract] [Full Text] [Related]

  • 12. Family influences on oral PrEP use among adolescent girls and young women in Kenya and South Africa.
    Ndimande-Khoza MN, Katz AWK, Moretlwe-Delany S, Travill D, Rousseau E, Omollo V, Morton J, Johnson R, Bekker LG, Bukusi EA, Baeten J, Celum C, van der Straten A, Roberts ST.
    PLoS One; 2023 Oct 10; 18(11):e0292529. PubMed ID: 37963171
    [Abstract] [Full Text] [Related]

  • 13. The Effect of Disclosure of PrEP Use on Adherence Among African Young Women in an Open-Label PrEP Study: Findings from HPTN 082.
    Beauchamp G, Hosek S, Donnell D, Chan KCG, Anderson PL, Dye BJ, Mgodi N, Bekker LG, Delany-Moretlwe S, Celum C, HPTN 082 study team.
    AIDS Behav; 2024 May 10; 28(5):1512-1521. PubMed ID: 37768427
    [Abstract] [Full Text] [Related]

  • 14. Factors that influence adolescent girls and young women's re-initiation or complete discontinuation from daily oral PrEP use: a qualitative study from Eastern Cape Province, South Africa.
    de Vos L, Mudzingwa EK, Fynn L, Atujuna M, Mugore M, Gandhi M, Celum C, Hosek S, Bekker LG, Daniels J, Medina-Marino A.
    J Int AIDS Soc; 2023 Sep 10; 26(9):e26175. PubMed ID: 37758649
    [Abstract] [Full Text] [Related]

  • 15. Stigma in the health clinic and implications for PrEP access and use by adolescent girls and young women: conflicting perspectives in South Africa.
    Nyblade L, Ndirangu JW, Speizer IS, Browne FA, Bonner CP, Minnis A, Kline TL, Ahmed K, Howard BN, Cox EN, Rinderle A, Wechsberg WM.
    BMC Public Health; 2022 Oct 14; 22(1):1916. PubMed ID: 36242000
    [Abstract] [Full Text] [Related]

  • 16. Adaptive HIV pre-exposure prophylaxis adherence interventions for young South African women: Study protocol for a sequential multiple assignment randomized trial.
    Velloza J, Poovan N, Ndlovu N, Khoza N, Morton JF, Omony J, Mkwanazi E, Grabow C, Donnell D, Munthali R, Baeten JM, Hosek S, Celum C, Delany-Moretlwe S.
    PLoS One; 2022 Oct 14; 17(4):e0266665. PubMed ID: 35417485
    [Abstract] [Full Text] [Related]

  • 17. Trust in the provider and accurate self-reported PrEP adherence among adolescent girls and young women in South Africa and Zimbabwe: HPTN 082 study.
    Beauchamp G, Donnell D, Hosek S, Anderson PL, Chan KCG, Dye BJ, Mgodi N, Bekker LG, Delany-Moretlwe S, Celum C.
    BMC Womens Health; 2023 May 19; 23(1):276. PubMed ID: 37208687
    [Abstract] [Full Text] [Related]

  • 18. PrEP use and HIV seroconversion rates in adolescent girls and young women from Kenya and South Africa: the POWER demonstration project.
    Celum CL, Bukusi EA, Bekker LG, Delany-Moretlwe S, Kidoguchi L, Omollo V, Rousseau E, Travill D, Morton JF, Mogaka F, O'Malley G, Barnabee G, van der Straten A, Donnell D, Parikh UM, Kudrick L, Anderson PL, Haberer JE, Wu L, Heffron R, Johnson R, Morrison S, Baeten JM, POWER Study Team.
    J Int AIDS Soc; 2022 Jul 19; 25(7):e25962. PubMed ID: 35822945
    [Abstract] [Full Text] [Related]

  • 19. Exploring adolescent girls and young women's PrEP-user profiles: qualitative insights into differentiated PrEP delivery platform selection and engagement in Cape Town, South Africa.
    Rousseau E, Sikkema KJ, Julies RF, Mazer K, O'Malley G, Heffron R, Morton JF, Johnson R, Celum C, Baeten JM, Bekker LG.
    J Int AIDS Soc; 2024 May 19; 27(5):e26254. PubMed ID: 38695101
    [Abstract] [Full Text] [Related]

  • 20. Psychosocial determinants of pre-exposure prophylaxis use among pregnant adolescent girls and young women in Cape Town, South Africa: A qualitative study.
    Haribhai S, Khadka N, Mvududu R, Mashele N, Bekker LG, Gorbach P, Coates TJ, Myer L, Joseph Davey DL.
    Int J STD AIDS; 2023 Jul 19; 34(8):548-556. PubMed ID: 36947792
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 54.